$8B Intermune (ITMN) Buyout Will Rally Biotech Stocks Today

http://burlingtoncarshow.ca/Dukes Look for a decent rally in the biotech sector today after Roche agreed to pay $8.3B for Intermune which is awaiting approval of pirfenidone,a treatment for idiopathic pulmonary fibrosis. The stock is up 36% in pre-market today and was already up 17% over one month.

follow site  


No comments yet.

Leave a Reply

where to buy erythromycin